A Prospective, Multicentre, Open Label, Non-Controlled, Observational, 24-Week Study in Patients Using NovoRapid (Insulin Aspart) and Levemir (Insulin Detemir) in a Basal-Bolus Regimen for Treatment of Type 1 Diabetes Mellitus in Romania.
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2016
At a glance
- Drugs Insulin aspart; Insulin detemir
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 07 Jun 2017 Biomarkers information updated
- 11 Dec 2009 Actual number of patients (417) added as reported by ClinicalTrials.gov
- 11 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.